Mahmoud Gimie

Array ( [id] => 19397141 [patent_doc_number] => 12071489 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-08-27 [patent_title] => Methods of converting biomass nucleic acids and converted biomass nucleic acid products and uses thereof [patent_app_type] => utility [patent_app_number] => 17/318845 [patent_app_country] => US [patent_app_date] => 2021-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 17281 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17318845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18589166 [patent_doc_number] => 11738038 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-29 [patent_title] => Highly active compounds against COVID-19 [patent_app_type] => utility [patent_app_number] => 17/306674 [patent_app_country] => US [patent_app_date] => 2021-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 55856 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17306674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18391446 [patent_doc_number] => 20230159664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => MECHANICAL TREATMENT OF POLYSACCHARIDE WITH HYDROPHOBIC ALCOHOL [patent_app_type] => utility [patent_app_number] => 17/923009 [patent_app_country] => US [patent_app_date] => 2021-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4641 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17958600 [patent_doc_number] => 20220339180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => Methods And Compositions For Treating Viral Diseases Using Combination Of Drugs [patent_app_type] => utility [patent_app_number] => 17/241130 [patent_app_country] => US [patent_app_date] => 2021-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3863 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17241130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17290854 [patent_doc_number] => 20210386693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-16 [patent_title] => METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID [patent_app_type] => utility [patent_app_number] => 17/240182 [patent_app_country] => US [patent_app_date] => 2021-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37508 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 673 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17240182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19049275 [patent_doc_number] => 20240091244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING PICROSIDE [patent_app_type] => utility [patent_app_number] => 18/264158 [patent_app_country] => US [patent_app_date] => 2021-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6434 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18264158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19325977 [patent_doc_number] => 12043642 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-23 [patent_title] => Process for the purification of oligonucleotides [patent_app_type] => utility [patent_app_number] => 17/236501 [patent_app_country] => US [patent_app_date] => 2021-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3159 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17236501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17713485 [patent_doc_number] => 11377468 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-05 [patent_title] => Antimicrobial compounds, compositions, and uses thereof [patent_app_type] => utility [patent_app_number] => 17/234430 [patent_app_country] => US [patent_app_date] => 2021-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 27188 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17234430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17532450 [patent_doc_number] => 20220111059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-14 [patent_title] => SELF-ASSEMBLED COMPLEX BASED ON THE BODY SUBSTANCE CAPABLE OF CONTROLLING EFFECTIVE COMPONENT DELIVERY RATE THROUGH REVERSIBLE SELF-ASSEMBLY AND SELF-DISASSEMBLY AND EFFECTIVE COMPONENT DELIVERY SYSTEM USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/234081 [patent_app_country] => US [patent_app_date] => 2021-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3863 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17234081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17154868 [patent_doc_number] => 20210315919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => SYSTEM FOR IMPROVING RECOVERY FROM SURGERY [patent_app_type] => utility [patent_app_number] => 17/229000 [patent_app_country] => US [patent_app_date] => 2021-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9606 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17229000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17843752 [patent_doc_number] => 11433094 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-06 [patent_title] => Water-activated mucoadhesive compositions to reduce intestinal absorption of nutrients [patent_app_type] => utility [patent_app_number] => 17/227484 [patent_app_country] => US [patent_app_date] => 2021-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 38 [patent_no_of_words] => 16643 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18376038 [patent_doc_number] => 20230151120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => Cellulose ethers with delayed solubility and having a reduced glyoxal content [patent_app_type] => utility [patent_app_number] => 17/917320 [patent_app_country] => US [patent_app_date] => 2021-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5129 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17712292 [patent_doc_number] => 11376271 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-07-05 [patent_title] => Methods of ameliorating the effects of alcoholic liver damage [patent_app_type] => utility [patent_app_number] => 17/221734 [patent_app_country] => US [patent_app_date] => 2021-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 25 [patent_no_of_words] => 11102 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17368200 [patent_doc_number] => 20220023252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => METHODS OF TREATING CHRONIC KIDNEY DISEASE WITH DAPAGLIFLOZIN [patent_app_type] => utility [patent_app_number] => 17/219992 [patent_app_country] => US [patent_app_date] => 2021-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22064 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17368200 [patent_doc_number] => 20220023252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => METHODS OF TREATING CHRONIC KIDNEY DISEASE WITH DAPAGLIFLOZIN [patent_app_type] => utility [patent_app_number] => 17/219992 [patent_app_country] => US [patent_app_date] => 2021-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22064 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17368200 [patent_doc_number] => 20220023252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => METHODS OF TREATING CHRONIC KIDNEY DISEASE WITH DAPAGLIFLOZIN [patent_app_type] => utility [patent_app_number] => 17/219992 [patent_app_country] => US [patent_app_date] => 2021-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22064 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17368200 [patent_doc_number] => 20220023252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => METHODS OF TREATING CHRONIC KIDNEY DISEASE WITH DAPAGLIFLOZIN [patent_app_type] => utility [patent_app_number] => 17/219992 [patent_app_country] => US [patent_app_date] => 2021-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22064 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19258055 [patent_doc_number] => 12018099 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-25 [patent_title] => Methods of modifying cellulose crystallinity [patent_app_type] => utility [patent_app_number] => 17/218372 [patent_app_country] => US [patent_app_date] => 2021-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 29 [patent_no_of_words] => 11367 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17218372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17154862 [patent_doc_number] => 20210315913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => BASIC CHEMOTHERAPEUTIC INTRATUMOUR INJECTION FORMULATION [patent_app_type] => utility [patent_app_number] => 17/218067 [patent_app_country] => US [patent_app_date] => 2021-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29348 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17218067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17227105 [patent_doc_number] => 20210353661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => INJECTABLE FORMULATIONS FOR TREATING CANCER [patent_app_type] => utility [patent_app_number] => 17/215491 [patent_app_country] => US [patent_app_date] => 2021-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17031 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17215491 [rel_patent_id] =>[rel_patent_doc_number] =>)